Ross Thomas M.'s Form 4 filing
Maxcyte, Inc. (MXCT) · filed Jul 10, 2024
- Accession no.
- 0001415889-24-019463
- Filed
- Jul 10, 2024
- Trade date
- Jul 8-9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $134.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ross Thomas M.CIK 0001874572 | Officer (EVP, GLOBAL SALES) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 | Common Stock | MOption exerciseAcquired | +19,802 | $1.64 | +$32,475.28 | 44,802 | Direct | |
| Jul 8, 2024 | Common Stock | SSaleDisposed | −19,802 | $4.03 | −$79,802.06 | 25,000 | Direct | |
| Jul 9, 2024 | Common Stock | MOption exerciseAcquired | +13,531 | $1.64 | +$22,190.84 | 38,531 | Direct | |
| Jul 9, 2024 | Common Stock | SSaleDisposed | −13,531 | $4.03 | −$54,529.93 | 25,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 | Common Stock | MOption exerciseDisposed | −19,802 | $0.00 | $0 | 46,865 | Direct | |
| Jul 9, 2024 | Common Stock | MOption exerciseDisposed | −13,531 | $0.00 | $0 | 33,334 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.